|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/36 | (2006.01) |
| A61K 38/4846 | (2013.01) | ||
| A61K 38/48 | (2006.01) | ||
| A61K 39/3955 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K2317/31 | (2013.01) | ||
| A61P 7/04 | (2006.01) | ||
| A61K 38/4833 | (2013.01) | ||
| C07K 16/36 | (2013.01) | ||
| A61P 7/04 | (2018.01) |
| (11) | Number of the document | 3283099 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16718244.3 |
| Date of filing the European patent application | 2016-04-07 | |
| (97) | Date of publication of the European application | 2018-02-21 |
| (45) | Date of publication and mention of the grant of the patent | 2022-03-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/057662 |
| Date | 2016-04-07 |
| (87) | Number | WO 2016/166014 |
| Date | 2016-10-20 |
| (30) | Number | Date | Country code |
| 15164045 | 2015-04-17 | EP |
| (72) |
CALATZIS, Andreas , DE
LECHNER, Katharina , DE
|
| (73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | COMBINATION THERAPY WITH COAGULATION FACTORS AND MULTISPECIFIC ANTIBODIES |
| COMBINATION THERAPY WITH COAGULATION FACTORS AND MULTISPECIFIC ANTIBODIES |